Record-Breaking Price Performance
The stock’s new peak at Rs. 2,925 represents a remarkable achievement for Acutaas Chemicals, marking the highest price level ever recorded for the company. This surge comes amid a bullish trend that has seen the stock outperform both its sector and the broader market indices. On the day of this milestone, the stock gained 1.30%, significantly outpacing the Sensex’s modest 0.25% rise. Over the past week, the stock has delivered a 7.27% return compared to the Sensex’s 0.14%, while the one-month performance stands out with a 23.19% gain against the Sensex’s decline of 4.75%.
Extending the timeframe, Acutaas Chemicals has generated an impressive 38.71% return over three months, vastly outperforming the Sensex’s negative 8.83%. The stock’s one-year return is particularly notable at 145.00%, dwarfing the Sensex’s 7.46% loss over the same period. Year-to-date, the stock has appreciated by 71.63%, while the Sensex has declined by 11.40%. Over three years, the stock has surged by 404.23%, compared to the Sensex’s 22.32% gain, underscoring the company’s sustained outperformance in the small-cap space.
Technical Indicators Confirm Bullish Momentum
Technical analysis supports the bullish narrative, with Acutaas Chemicals trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The overall technical trend is classified as bullish, a status that has been in place since early February 2026 when the stock crossed the ₹1,935.75 level. Key technical indicators such as MACD, Bollinger Bands, KST, Dow Theory, and On-Balance Volume (OBV) all signal positive momentum on both weekly and monthly charts. Immediate support is identified at the 52-week low of ₹1,059.05, while the stock has surpassed major resistance levels at ₹1,850.05 (200 DMA), ₹2,160.00 (100 DMA), and ₹2,656.50 (20 DMA), culminating in the recent all-time high.
Strong Financial Fundamentals Underpinning Growth
Acutaas Chemicals’ ascent to its record price is underpinned by solid financial performance. The company has demonstrated healthy long-term growth, with net sales expanding at an annual rate of 26.68% and operating profit growing at an even more robust 47.03%. Net profit growth has kept pace, increasing by 26.42%, with the company delivering outstanding results in the quarter ending March 2026.
Key quarterly metrics highlight the company’s operational strength: net sales reached a record ₹432.75 crores, operating profit margin stood at 42.41%, and profit before tax (excluding other income) hit ₹172.69 crores. The company’s return on capital employed (ROCE) for the half-year period is an impressive 28.77%, while the inventory turnover ratio is at a high 5.79 times, indicating efficient asset utilisation. Earnings per share for the quarter reached ₹16.09, reflecting strong profitability.
Quality and Capital Structure
Acutaas Chemicals is recognised as a good quality company based on its long-term financial performance. The company maintains a very low debt profile, with an average debt-to-equity ratio of just 0.05 times and negligible net debt, effectively operating as a net cash company. Interest coverage is strong, with an average EBIT to interest ratio of 49.70 times, underscoring the company’s ability to comfortably service its debt obligations.
The company’s capital structure and growth metrics have earned it an excellent quality grade, supported by a 5-year sales growth CAGR of 26.68% and EBIT growth of 47.03%. Institutional investors hold a significant 39.1% stake in the company, having increased their holdings by 0.72% over the previous quarter, reflecting confidence in the company’s fundamentals.
Valuation Metrics Reflect Premium Positioning
While Acutaas Chemicals’ valuation metrics indicate a premium positioning, these reflect the company’s strong growth and quality profile. The stock trades at a price-to-earnings (P/E) ratio of 67 times (TTM) and a price-to-book value (P/BV) of 14.33 times. Enterprise value multiples are also elevated, with EV/EBITDA at 48.94 times and EV/EBIT at 52.91 times. The PEG ratio stands at 0.53, suggesting that earnings growth is supporting the high valuation.
Dividend metrics show a modest yield of 0.05%, with a recent dividend payout of Rs. 1.5 per share and a payout ratio of 7.74%. The ex-dividend date was 18 September 2025.
Market Recognition and Rankings
Acutaas Chemicals is ranked among the top 1% of companies rated by MarketsMOJO across a universe of over 4,000 stocks. It holds the 15th position among small-cap companies and ranks 22nd across the entire market. The company’s Mojo Score stands at 82.0, reflecting a strong buy rating, an upgrade from its previous buy grade as of 6 October 2025.
Consistent Positive Results and Market Outperformance
The company has reported positive results for seven consecutive quarters, demonstrating consistent operational strength. Its market-beating performance is evident not only in the recent price appreciation but also in its ability to outperform the BSE500 index over multiple time horizons, including one year, three months, and three years.
Summary of Key Financial and Market Data as of 21 May 2026
Price: Rs. 2,923.00 (All-time high)
Market Cap Grade: Small-cap
Day Change: +1.30%
52-Week Range: Rs. 1,059.05 – Rs. 2,925.00
Institutional Holdings: 39.1%
Debt to Equity (avg): 0.05 times
ROCE (HY): 28.77%
Net Sales (Quarterly): Rs. 432.75 crores
EPS (Quarterly): Rs. 16.09
Mojo Grade: Strong Buy (Score 82.0)
Acutaas Chemicals Ltd’s achievement of an all-time high price reflects a combination of strong financial results, robust growth, and sustained market confidence. The company’s performance across multiple timeframes and its technical and fundamental strength underscore its prominent position within the Pharmaceuticals & Biotechnology sector.
